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Figure A. Education by age group among urban and rural men and women in 
Brong Ahafo, Ghana. Left panels (A) and (C): estimates by age group are for urban 
females (purple circles) and rural females (green circles). Right panels (B) and (D): 
estimates by age group are for urban males (purple triangles) and rural males 
(green triangles). Error bars denote 95% confidence intervals. JSS = Junior 
Secondary School (usually attended through age 15).  
 
  
 Figure B. Mean systolic and diastolic blood pressure by age group in urban 
and rural men and women in Brong Ahafo, Ghana. Left panels (A) and (C): mean 
estimates by age group for urban females (purple circles) and rural females (green 
circles). Right panels (B) and (D): mean estimates by age group for urban males 
(purple triangles) and rural males (green triangles). Error bars denote 95% 
confidence intervals.  
 
  
 Figure C. Mean BMI and overweight prevalence by age group in urban and 
rural men and women in Brong Ahafo, Ghana. Left panels (A) and (C): estimates 
by age group for urban females (purple circles) and rural females (green circles). In 
the right panels (B) and (D), estimates by age group are depicted for urban males 
(purple triangles) and rural males (green triangles). Error bars denote 95% 
confidence intervals. Overweight is defined as BMI ≥ 25 kg/m2. 
 
  
 Figure D. Mean fasting glucose and prevalence of impaired fasting glucose by 
age group in urban and rural men and women in Brong Ahafo, Ghana. Left 
panels (A) and (C): urban females (purple circles) and rural females (green circles). 
Right panels (B) and (D): urban males (purple triangles) and rural males (green 
triangles). Error bars denote 95% confidence intervals. Impaired fasting glucose is 
defined according to the WHO cut-point (glucose ≥ 110 mg/dL). 
 Figure E. The BMI-adjusted effect of urban/rural environment on 
cardiovascular risk factors in Brong Ahafo, Ghana. Absolute differences between 
urban and rural standardized means (with 95% confidence intervals) are depicted 
for each risk factor, with colors representing the group with the higher mean 
(purple: urban; green: rural). Data were adjusted for age, sex, and BMI. 
 
  
 Figure F. Mean high-density lipoprotein cholesterol by age group in urban and 
rural men and women in Brong Ahafo, Ghana. (A) mean estimates by age group 
for urban females (purple circles) and rural females (green circles). (B) mean 
estimates by age group for urban males (purple triangles) and rural males (green 
triangles). Error bars denote 95% confidence intervals.  
 
  
 Figure G. Mean t-PA and PAI-1 levels by age group in urban and rural men and 
women in Brong Ahafo, Ghana. Left panels (A) and (C): urban females (purple 
circles) and rural females (green circles). Right panels (B) and (D): urban males 
(purple triangles) and rural males (green triangles). Error bars denote 95% 
confidence intervals.  
 
  
Table A. Age-standardized prevalence rates and 95% confidence intervals of dichotomous risk factors in the Ghanaian cohort. 
 
 
Females 
 
Males Urban Rural 
 Urban Rural p-value Urban  Rural p-value 
p-value  
by sex 
p-value  
by sex 
N 1293 583  972 469  
  
Hypertension 
0.32 (0.30, 
0.35) 
 0.21  
(0.18, 0.24) <.001 
0.34 (0.31, 
0.37) 
0.20 (0.16, 
0.24) <.001 0.316 0.690 
IFG (>100 mg/dL)  
0.29  
(0.27, 0.32) 
 0.31  
(0.28, 0.35) 0.380 
0.23 (0.20, 
0.26) 
0.19 (0.16, 
0.23) 0.084 0.001 <.001 
IFG (>110 mg/dL) 
0.12  
(0.10, 0.14) 
 0.10 (0.08, 
0.13) 0.207 
0.10 (0.09, 
0.12) 
0.05 (0.03, 
0.07) 0.001 0.133 0.003 
Diabetes 
0.07  
(0.05, 0.08) 
 0.03 (0.02, 
0.05) <.001 
0.06 (0.04, 
0.07) 
0.02 (0.01, 
0.03) <.001 0.342 0.307 
Overweight  
0.60  
(0.58, 0.63) 
 0.26 (0.22, 
0.29) <.001 
0.35 (0.32, 
0.38) 
0.11 (0.08, 
0.14) <.001 <.001 <.001 
Obesity 
0.26  
(0.24, 0.28) 
 0.05 (0.04, 
0.07) <.001 
0.07 (0.05, 
0.09) 
0.00 (0.00, 
0.01) <.001 <.001 <.001 
Hypercholesterolemia 
0.31  
(0.28, 0.33) 
 0.10 (0.08, 
0.13) <.001 
0.22 (0.20, 
0.25) 
0.07 (0.05, 
0.09) <.001 <.001 0.086 
High TG 
0.21  
(0.19, 0.24) 
 0.26 (0.23, 
0.30) 0.017 
0.28 (0.25, 
0.31) 
0.27 (0.23, 
0.31) 0.691 0.001 0.715 
Low HDL-C 
0.26  
(0.23, 0.29)1 
 0.38 (0.32, 
0.43)2 <.001 
0.40 (0.36, 
0.44)3 
0.38 (0.32, 
0.45)4 0.592 <.001 0.946 
High LDL-C 
0.30  
(0.27, 0.33)1 
 0.11 (0.08, 
0.15)2 <.001 
0.22 (0.19, 
0.25)3 
0.05 (0.03, 
0.08)4 <.001 <.001 0.014 
Smoker 
0.00  
(0.00, 0.00) 
 0.02 (0.01, 
0.03) <.001 
0.03 (0.02, 
0.04)) 
0.16 (0.13, 
0.20) <.001 <.001 <.001 
Any schooling 
0.88  
(0.86, 0.90) 
 0.44 (0.40, 
0.48) <.001 
0.96 (0.95, 
0.98) 
0.64 (0.60, 
0.68) <.001 <.001 <.001 
Schooling >JSS 
0.30 (0.27, 
0.33) 
 0.02 (0.01, 
0.03) 
<.001 
0.48 (0.45, 
0.52) 
0.05 (0.04, 
0.08) <.001 
<.001 0.007 
 
1n=955, 2n=317, 3n=722, 4n=225 
 
Hypertension: SBP ≥140 or DBP ≥90 or current use of medication; IFG: impaired fasting glucose; Diabetes: glucose ≥126 
mg/dL or current use of medication; Overweight: BMI ≥25; Obese: BMI ≥30; Hypercholesterolemia: TC ≥200; High TG: TG ≥ 
110 mg/dL; Low HDL-C: HDL ≤40 mg/dL; High LDL-C: LDL ≥130; Schooling >JSS: education beyond Junior Secondary School; 
Prevalence age-standardized to WHO 2000-2025 standard population. 
